Purespring Therapeutics and SwanBio Therapeutics announce licensing agreement for use of FunSel screening platform FunSel is Purespring’s proprietary in-vivo ‘gene search engine’, which allows functional selection of therapeutic factors…
Purespring strengthens senior leadership with appointment of Chief Medical Officer and Chief Development Officer Purespring Therapeutics, a pioneering gene therapy company focused on transforming the treatment of kidney diseases,…
Purespring appoints new Chief Executive Officer Purespring Therapeutics (Purespring), a kidney-focused AAV gene therapy company, announces that it is intended to…
Syncona founds Purespring with a £45m Series A Financing Syncona Ltd, a leading healthcare company focused on founding, building and funding a portfolio of…